Recent development in biodegradable nanovehicle delivery system-assisted immunotherapy

Biomaterials Science
Zhenfu WenShiguo Sun

Abstract

Based on the stimulation of the patient's own innate and adaptive immunity, immunotherapy is used in tumor treatment, and in recent years, it has developed rapidly. To generate strong and long-lasting antitumor immune responses and to boost clinical efficiency, various nanovehicle delivery systems (NDSs) have been designed to achieve specific release and avoid premature leakage in the delivery process. However, most of them are nondegradable, and they are taken up by the liver and spleen. This process leads to the accumulation of these substances in the human body, raising long-term toxicity concerns and causing potential undesirable side effects. To solve this problem, biodegradable NDSs (BNDSs) have been developed. Once these substances reach their target, they can only be degraded under specific internal or external stimuli, such as enzymes, irradiation, temperature, redox potential, pH, or a combination of these stimuli. Therefore, they are quite significant for potential clinical applications. In this review article, we highlight the recent literature on the design and working mechanism of various BNDSs. According to their type and characteristics, BNDSs are categorized as follows: (1) polymers, (2) lipid based materials, ...Continue Reading

References

Jan 1, 1978·Annals of the New York Academy of Sciences·G Gregoriadis
Oct 1, 1990·The Journal of Experimental Medicine·B GansbacherE Gilboa
Jan 1, 1995·Annual Review of Immunology·D M Pardoll
Aug 1, 1994·Pharmaceutical Research·L IllumS S Davis
Sep 2, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·N MurthyA S Hoffman
Sep 30, 1999·International Journal of Pharmaceutics·D HenristJ P Remon
Nov 26, 1999·The Journal of Investigative Dermatology·T J BrownJ R Fraser
Jan 19, 2000·Molecular Medicine Today·M StubbsC L Bashford
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
May 18, 2001·Journal of Pharmaceutical Sciences·T Lian, R J Ho
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Dec 10, 2003·The Lancet Oncology·J C CoffeyH P Redmond
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Mar 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E R O'BrienUNKNOWN CAELYX Breast Cancer Study Group
Aug 3, 2004·Nature Reviews. Immunology·Jukka Vakkila, Michael T Lotze
Oct 14, 2004·Journal of the American Chemical Society·Aart A van ApeldoornCees Otto
Nov 24, 2004·Pharmaceutical Research·Rocío Alvarez-RománHatem Fessi
Apr 19, 2005·Molecular Pharmaceutics·Jayanth Panyam, Vinod Labhasetwar
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·John J DonnellyMargaret A Liu
Sep 13, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luca CostantinoFlavio Forni
Jun 24, 2006·Nature Reviews. Cancer·Ana P CastanoMichael R Hamblin
Jul 4, 2006·Journal of Biomedical Materials Research. Part a·Zhidao XiaZhanfeng Cui
Aug 29, 2006·Drug Discovery Today·Arun K IyerHiroshi Maeda
Oct 25, 2006·Molecular Membrane Biology·Dileep P VangasseriLeaf Huang
Aug 9, 2007·Advanced Drug Delivery Reviews·Jaspreet K Vasir, Vinod Labhasetwar
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Alessandro FedericoCarmela Loguercio
Oct 19, 2007·Cancer Research·Ian CheongShibin Zhou
Feb 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·Daniel P WermelingAudra L Stinchcomb
Mar 7, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Angeles JuarranzSalvador González
Jul 11, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhi Ping XuGao Qing Max Lu
Jul 18, 2008·Journal of the American Chemical Society·Eric M BachelderJean M J Fréchet
Jul 26, 2008·Nature Nanotechnology·Demir AkinRashid Bashir
Aug 5, 2008·Molecular Pharmaceutics·Frank AlexisOmid C Farokhzad
Sep 11, 2008·Nature Reviews. Genetics·Michele A Kutzler, David B Weiner
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michail V SitkovskyAkio Ohta
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Bernhard OrtelPiergiacomo Calzavara-Pinton
Mar 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kyle E BroadersJean M J Fréchet
May 12, 2009·Immunological Reviews·Chao WangTania H Watts
Sep 29, 2009·Colloids and Surfaces. B, Biointerfaces·Avnesh KumariSubhash C Yadav

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
surgical resection
xenograft
transfect
fluorescence imaging
PCL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Anna Puiggalí-JouCarlos Alemán
© 2021 Meta ULC. All rights reserved